欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/H/5611/001
药品名称Lunploro 3%/0.3%/0.3% medicinal gas, compressed
活性成分
    • Acetylene 0.3 %
    • Carbon monoxide 0.3 %
    • Methane 0.3 %
剂型Medicinal gas, compressed
上市许可持有人Air Liquide Sante International 75 Quai D Orsay 75007 Paris France
参考成员国 - 产品名称Netherlands (NL)
Lunploro 0.3%/0.3%/0.3% medicinaal gas, samengeperst
互认成员国 - 产品名称
    • Austria (AT)
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Sweden (SE)
    • Norway (NO)
    • Germany (DE)
      PulmixAL CO/CH4/C2H2, 0.3%/0.3%/0.3%, Gas zur medizinischen Anwendung, druckverdichtet
    • Denmark (DK)
      Lunploro
    • Belgium (BE)
      Lunploro 0,3%/0,3%/0,3% gaz médicinal comprimé
    • Luxembourg (LU)
许可日期2023/10/05
最近更新日期2024/11/14
药物ATC编码
    • V04CX Other diagnostic agents
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Bibliographic Art 10 a Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase